|
🐜
|
An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28
16 auth.
D. Owen,
A. Yeo,
R. Gunn,
Kijoung Song,
G. Wadsworth,
Andrew Lewis,
C. Rhodes,
D. Pulford,
I. Bennacef,
C. Parker,
...
Pamela Stjean,
L. Cardon,
V. Mooser,
P. Matthews,
E. Rabiner,
J. Rubio
|
9 |
2011 |
9
🐜
|
|
🐜
|
GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer's Disease Brain and Improves Cognitive Performance in Preclinical Models
38 auth.
A. Medhurst,
Alan R. Atkins,
I. Beresford,
K. Brackenborough,
Michael A Briggs,
A. Calver,
J. Cilia,
J. Cluderay,
B. Crook,
John B Davis,
Rebecca K. Davis,
Robert P. Davis,
L. Dawson,
A. Foley,
J. Gartlon,
...
M. I. Gonzalez,
Teresa Heslop,
W. Hirst,
C. Jennings,
Declan Jones,
L. Lacroix,
A. Martyn,
S. Ociepka,
Alison M. Ray,
C. Regan,
Jennifer C. Roberts,
Joanne Schogger,
E. Southam,
T. Stean,
B. Trail,
N. Upton,
G. Wadsworth,
J. Wald,
Trevor White,
J. Witherington,
M. Woolley,
A. Worby,
David M. Wilson
|
8 |
2007 |
8
🐜
|
|
🐬
|
Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety
Scott Murray Weiss,
G. Wadsworth,
Allan Fletcher,
Colin T. Dourish
|
7 |
1998 |
7
🐬
|
|
🐜
|
The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat.
14 auth.
Kelly Stanhope,
Naheed Mirza,
M. Bickerdike,
J. Bright,
Nick Harrington,
M. Hesselink,
Guy Anthony Oakdene Cour Winnersh Kennett,
S. Lightowler,
M. Sheardown,
R. Syed,
...
R. Upton,
G. Wadsworth,
Scott Murray Weiss,
A. Wyatt
|
6 |
2001 |
6
🐜
|
|
🐬
|
A comparative assessment of the efficacy and side-effect liability of neuroprotective compounds in experimental stroke
D. Dawson,
G. Wadsworth,
A. Palmer
|
6 |
2001 |
6
🐬
|
|
🐜
|
Potent achiral agonists of the growth hormone secretagogue (ghrelin) receptor. Part 2: Lead optimisation.
18 auth.
J. Witherington,
L. Abberley,
Michael A Briggs,
K. L. Collis,
D. K. Dean,
A. Gaiba,
N. King,
H. Kraus,
Nicola Shuker,
J. G. Steadman,
...
A. Takle,
G. Sanger,
G. Wadsworth,
Sharon Butler,
Fiona McKay,
A. Muir,
Kim Y Winborn,
T. Heightman
|
3 |
2008 |
3
🐜
|
|
🐜
|
O3–05–01: GSK189254 – a novel H3 receptor antagonist that binds to H3 receptors in the human brain and improves cognitive performance in preclinical models
25 auth.
A. Medhurst,
B. Crook,
S. Ociepka,
Robert P. Davies,
A. Calver,
Alison M. Ray,
T. Stean,
B. Trail,
G. Wadsworth,
K. Brackenborough,
Rebecca K. Davis,
M. Isabel Gonzalez,
D. Virley,
Martin I. Smith,
Jennifer C. Roberts,
...
Sharlin Ahmed,
Teresa Heslop,
Joanne Schogger,
Trevor White,
Michael A Briggs,
J. Wald,
A. Foley,
C. Regan,
J. Witherington,
David M. Wilson
|
0 |
2006 |
0
🐜
|
|
🐬
|
An investigation of the mechanism responsible for the proconvulsant effect of caffeine in mice
S. Lightowler,
C. McNicoll,
R. Upton,
G. Wadsworth,
S. Weiss
|
0 |
2001 |
0
🐬
|
|
🐜
|
P2-010 Protection against neuroinflammation and dopamine cell loss by P38 inhibition in vivo
9 auth.
D. Sunter,
A. Swales,
M. Vidgeon-Hart,
A. Billinton,
P. Pugh,
G. Wadsworth,
...
M. I. Smith,
L. Tilling,
N. Upton
|
0 |
2004 |
0
🐜
|
